Abuse-Resistant Bead Formulation for Opioid Deterrence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceutical compositions susceptible to abuse, such as opioids, can be easily manipulated or extracted for non-therapeutic use, leading to misuse and abuse, as they lack effective deterrents against crushing, inhalation, or injection.
Innovation Solution
An oral pharmaceutical composition comprising two populations of beads: one containing the active ingredient and another with a gelling agent and semi-permeable coating, which forms a uniform, viscous mass upon contact with water, making extraction difficult by creating a dispersed, viscous mass that prevents isolation or injection of the active ingredient.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a gelling agent is incorporated into the dosage form to prevent abuse, then abuse resistance is improved, but the extraction difficulty increases making it harder to obtain the active ingredient
Solution Approach 1:
The dosage form is divided into multiple bead populations with distinct functions: drug-containing beads for therapeutic effect and gelling agent-containing beads for abuse deterrence. This segmentation allows the gelling agent to be distributed throughout the formulation, creating localized gel barriers that trap active ingredient upon contact with liquids, thereby preventing extraction while maintaining therapeutic efficacy.
Solution Approach 2:
The gelling agent acts as an intermediary substance between the active ingredient and the external environment. When liquid contacts the dosage form, the gelling agent hydrates and forms a gel matrix that physically entraps the active ingredient, preventing its extraction. This intermediary gel layer serves as a protective barrier without interfering with the intended therapeutic release of the drug.
2Reliability
If the gelling agent forms a uniform viscous mass upon contact with water, then extraction is prevented, but the pharmacokinetic characteristics must be maintained
Solution Approach 1:
Different bead populations possess different local qualities: drug-containing beads are designed for controlled drug release with specific surface properties and porosity, while gelling agent beads are designed to hydrate and form gel. This local differentiation ensures that the gelling action occurs only where needed (in the presence of excess liquid indicating abuse), while the drug-containing beads maintain their pharmacokinetic properties for therapeutic effect.
Solution Approach 2:
The gelling agent undergoes a parameter change upon contact with liquid - transitioning from a dry powder state to a hydrated gel state with dramatically increased viscosity. This parameter change is triggered only when the dosage form is exposed to excessive liquid (indicating attempted extraction or injection), allowing the formulation to maintain normal pharmacokinetic characteristics during legitimate use while preventing abuse.
3Reliability
If the composition is designed to deter abuse by making extraction difficult, then abuse potential is reduced, but the complexity of the formulation increases
Solution Approach 1:
The formulation merges multiple functional components into a single integrated bead population system. Drug-containing beads and gelling agent-containing beads are combined in the same dosage form, creating a unified formulation that simultaneously provides therapeutic effect and abuse deterrence. This merging approach avoids the need for separate protective mechanisms while achieving both therapeutic and anti-abuse objectives.
Solution Approach 2:
The gelling agent serves multiple functions: it acts as a filler/extender in the formulation, provides abuse deterrence through gel formation, and contributes to the overall structure and stability of the dosage form. This multi-functionality reduces the need for additional specialized components, thereby limiting the increase in formulation complexity while achieving comprehensive abuse deterrence.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively deters abuse by making it difficult to extract or inject the active ingredient, while maintaining the pharmacokinetic characteristics and bioavailability of the drug, thus reducing misuse and abuse potential without compromising the drug's intended release profile.
Implementation Method 1
the gelling agent contained in the second bead population, upon contact with water or some other liquid, forms a uniform, viscous mass
Implementation Method 2
a permeable or semi-permeable coating which restricts, but does not completely prevent, the ingress of water into the gelling agent-containing beads
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a composition comprising pharmaceutical active ingredients which are susceptible to, or have potential for, abuse. The invention provides an oral pharmaceutical composition comprising a first population of beads and a second population of beads. The first bead population comprises a pharmaceutically active ingredient susceptible to, or having the potential for, abuse. The second bead population comprises a gelling agent and a coating substantially surrounding the gelling agent, but containing no pharmaceutically active ingredient. The first bead population and the second bead population are physically separable, but visually indistinguishable to the naked eye. Upon ingress of water into the second population of beads, the gelling agent is caused to swell forming a viscous mass inhibiting or preventing the extraction of the active ingredient.